Legal Representation
Attorney
William R. Samuels
USPTO Deadlines
Next Deadline
2053 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-03-04)
Due Date
March 04, 2031
Grace Period Ends
September 04, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
20 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Mar 4, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
Mar 4, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
Jan 14, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Jan 14, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Jan 8, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Dec 12, 2024 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
Dec 12, 2024 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
Dec 12, 2024 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
Oct 23, 2024 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Oct 22, 2024 | ALIE | A | ASSIGNED TO LIE | Loading... |
Oct 22, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Oct 22, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Jul 12, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Apr 17, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Apr 17, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Apr 17, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Apr 10, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Sep 8, 2023 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
Sep 7, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Aug 12, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Biotechnological platform technology, namely, biological nanoparticles, recombinant viruses, and adenoviruses for gene delivery to biological cells that includes recombinant adeno-associated viral (rAAV) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy, RNA interference (RNAi), and cell therapy
First Use Anywhere:
Sep 1, 2014
First Use in Commerce:
Sep 1, 2014
Additional Information
Design Mark
The mark consists of a cluster of circles of varying size which create a larger circle. The cluster of circles surround a circle with a triangular shape inside.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
005